Race Oncology Past Earnings Performance

Past criteria checks 0/6

Race Oncology's earnings have been declining at an average annual rate of -26.5%, while the Biotechs industry saw earnings growing at 12.4% annually. Revenues have been growing at an average rate of 68.4% per year.

Key information

-26.5%

Earnings growth rate

-10.7%

EPS growth rate

Biotechs Industry Growth9.6%
Revenue growth rate68.4%
Return on equity-54.7%
Net Margin-192.1%
Last Earnings Update31 Dec 2023

Recent past performance updates

No updates

Recent updates

We Think Race Oncology (ASX:RAC) Needs To Drive Business Growth Carefully

May 10
We Think Race Oncology (ASX:RAC) Needs To Drive Business Growth Carefully

We're Not Very Worried About Race Oncology's (ASX:RAC) Cash Burn Rate

Jan 23
We're Not Very Worried About Race Oncology's (ASX:RAC) Cash Burn Rate

Here's Why We're Not Too Worried About Race Oncology's (ASX:RAC) Cash Burn Situation

Oct 05
Here's Why We're Not Too Worried About Race Oncology's (ASX:RAC) Cash Burn Situation

Companies Like Race Oncology (ASX:RAC) Are In A Position To Invest In Growth

Jun 20
Companies Like Race Oncology (ASX:RAC) Are In A Position To Invest In Growth

We're Interested To See How Race Oncology (ASX:RAC) Uses Its Cash Hoard To Grow

Feb 17
We're Interested To See How Race Oncology (ASX:RAC) Uses Its Cash Hoard To Grow

Here's Why We're Not At All Concerned With Race Oncology's (ASX:RAC) Cash Burn Situation

Oct 14
Here's Why We're Not At All Concerned With Race Oncology's (ASX:RAC) Cash Burn Situation

Here's Why We're Not Too Worried About Race Oncology's (ASX:RAC) Cash Burn Situation

Apr 01
Here's Why We're Not Too Worried About Race Oncology's (ASX:RAC) Cash Burn Situation

We're Hopeful That Race Oncology (ASX:RAC) Will Use Its Cash Wisely

Apr 05
We're Hopeful That Race Oncology (ASX:RAC) Will Use Its Cash Wisely

What Percentage Of Race Oncology Limited (ASX:RAC) Shares Do Insiders Own?

Mar 01
What Percentage Of Race Oncology Limited (ASX:RAC) Shares Do Insiders Own?

How Much Are Race Oncology Limited (ASX:RAC) Insiders Taking Off The Table?

Jan 07
How Much Are Race Oncology Limited (ASX:RAC) Insiders Taking Off The Table?

Revenue & Expenses Breakdown

How Race Oncology makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

ASX:RAC Revenue, expenses and earnings (AUD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Dec 236-11311
30 Sep 234-1139
30 Jun 233-1038
31 Mar 232-1037
31 Dec 221-1137
30 Sep 221-1146
30 Jun 221-1146
31 Mar 221-1045
31 Dec 211-944
30 Sep 211-843
30 Jun 210-632
31 Mar 210-532
31 Dec 200-431
30 Sep 200-421
30 Jun 200-421
31 Mar 200-321
31 Dec 190-311
30 Sep 190-311
30 Jun 190-421
31 Mar 190-421
31 Dec 180-531
30 Sep 180-641
30 Jun 180-641
31 Mar 180-641
31 Dec 170-631
30 Sep 170-531
30 Jun 170-431
31 Mar 170-321
31 Dec 160-220
30 Sep 160-110
30 Jun 160000
31 Mar 160000
31 Dec 150000
30 Sep 150000
30 Jun 150000

Quality Earnings: RAC is currently unprofitable.

Growing Profit Margin: RAC is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: RAC is unprofitable, and losses have increased over the past 5 years at a rate of 26.5% per year.

Accelerating Growth: Unable to compare RAC's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: RAC is unprofitable, making it difficult to compare its past year earnings growth to the Biotechs industry (-2.6%).


Return on Equity

High ROE: RAC has a negative Return on Equity (-54.69%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.